FDA plans ahead for personalised and genomic medicine

19 August 2011

New guidance on making applications for the approval of genomic, proteomic, and imaging-based biomarkers, and on how medical device applications are assessed (including consideration of the companion diagnostics) has also been released by the regulator this month.

More from us

Genomics and policy news